BRCA1 promoter methylation is a marker of better response to platinum–taxane-based therapy in sporadic epithelial ovarian cancer
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
BRCA1 promoter methylation is a marker of better response to platinum–taxane-based therapy in sporadic epithelial ovarian cancer
Authors
Keywords
Ovarian cancer, <em class=EmphasisTypeItalic >BRCA1</em>, Promoter methylation, EOC
Journal
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Volume 140, Issue 9, Pages 1457-1463
Publisher
Springer Nature
Online
2014-05-13
DOI
10.1007/s00432-014-1704-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- BRCA1 promoter hypermethylation and protein expression in ovarian carcinoma—an Indian study
- (2014) V. Shilpa et al. TUMOR BIOLOGY
- BRCA1 promoter methylation is a marker of better response to anthracycline-based therapy in sporadic TNBC
- (2013) T. Ignatov et al. BREAST CANCER RESEARCH AND TREATMENT
- BRCA1epigenetic inactivation predicts sensitivity to platinum-based chemotherapy in breast and ovarian cancer
- (2012) Olafur A. Stefansson et al. Epigenetics
- Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patients
- (2011) P. M. L. H. Vencken et al. ANNALS OF ONCOLOGY
- Breast cancer 1 (BRCA1) protein expression as a prognostic marker in sporadic epithelial ovarian carcinoma: an NCIC CTG OV.16 correlative study
- (2011) J. I. Weberpals et al. ANNALS OF ONCOLOGY
- BRCA1 is both a prognostic and predictive biomarker of response to chemotherapy in sporadic epithelial ovarian cancer
- (2011) Judith E. Carser et al. GYNECOLOGIC ONCOLOGY
- Association of BRCA1 and BRCA2 Mutations With Survival, Chemotherapy Sensitivity, and Gene Mutator Phenotype in Patients With Ovarian Cancer
- (2011) Da Yang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A critical re-appraisal of BRCA1 methylation studies in ovarian cancer
- (2010) Emir Senturk et al. GYNECOLOGIC ONCOLOGY
- Methylation of the Tumor Suppressor Protein, BRCA1, Influences Its Transcriptional Cofactor Function
- (2010) Irene Guendel et al. PLoS One
- Cancer Statistics, 2009
- (2009) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Utility of Gene Promoter Methylation in Prediction of Response to Platinum-Based Chemotherapy in Epithelial Ovarian Cancer (EOC)
- (2009) Parvesh Chaudhry et al. CANCER INVESTIGATION
- Systemic therapy in recurrent ovarian cancer: current treatment options and new drugs
- (2009) Philipp Harter et al. Expert Review of Anticancer Therapy
- BRCA1 and implications for response to chemotherapy in ovarian cancer
- (2009) Jennifer E. Quinn et al. GYNECOLOGIC ONCOLOGY
- Methylation and protein expression of DNA repair genes: association with chemotherapy exposure and survival in sporadic ovarian and peritoneal carcinomas
- (2009) Elizabeth M Swisher et al. Molecular Cancer
- Methylation is less abundant in BRCA1-associated compared with sporadic breast cancer
- (2008) K. P. M. Suijkerbuijk et al. ANNALS OF ONCOLOGY
- Effect ofBRCA1/2Mutations on Long-Term Survival of Patients With Invasive Ovarian Cancer: The National Israeli Study of Ovarian Cancer
- (2007) Angela Chetrit et al. JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now